Skip to main content

Find Clinical Trials

Home
Conditions
Red-Cell Aplasia, Pure

Clinical trial condition

Red-Cell Aplasia, Pure

Explore clinical trials studying Red-Cell Aplasia, Pure. Study availability and eligibility vary by location and protocol.

4 public trials 0 recruiting studies

Refine in advanced search Browse all conditions

Red-Cell Aplasia, Pure trial results

Completed

Rituximab to Treat Moderate Aplastic Anemia, Pure Red Cell Aplasia, or Diamond Blackfan Anemia

NCT00229619

Conditions: Anemia, Anemia, Aplastic, Anemia, Diamond-Blackfan, +9 more
Locations: National Institutes of Health Clinical Center, 9000 Rockville Pike Bethesda, Maryland, United States

View Trial Details

Completed

A Study to Observe the Number of Patients Who Develop Pure Red Cell Aplasia (PRCA, a Rare Form of Anemia) While Receiving Epoetin Alfa or Other Recombinant Erythropoietins

NCT00211029

Conditions: Anemia, Chronic Disease, Disease Attributes, +14 more
Locations: Not specified

View Trial Details

Completed

Study to Monitor the Incidence of Pure Red Cell Aplasia (PRCA) and/or Antibodies to Erythropoietin Among Participants Receiving Epoetin Alfa or Another Erythropoietin

NCT00210951

Conditions: Anemia, Chronic Disease, Chronic Renal Failure, +15 more
Locations: Not specified

View Trial Details

Completed

Study of Allogeneic Bone Marrow Transplantation Using Matched, Related Donors in Patients With Nonmalignant Hematologic Disorders

NCT00005893

Conditions: Agranulocytosis, Anemia, Anemia, Aplastic, +26 more
Locations: Fairview University Medical Center Minneapolis, Minnesota, United States

View Trial Details